Niels Rasmussen

Active 1983–2020

33
Papers
18,833
Citations
32
h-index
33
i10-index

Citations

Citations per year for Niels Rasmussen1983: 1 citations1985: 2 citations1986: 1 citations1987: 4 citations1988: 8 citations1989: 12 citations1990: 28 citations1991: 18 citations1992: 20 citations1993: 27 citations1994: 16 citations1995: 25 citations1996: 17 citations1997: 16 citations1998: 27 citations1999: 22 citations2000: 42 citations2001: 30 citations2002: 17 citations2003: 38 citations2004: 32 citations2005: 50 citations2006: 60 citations2007: 67 citations2008: 45 citations2009: 48 citations2010: 112 citations2011: 70 citations2012: 73 citations2013: 95 citations2014: 92 citations2015: 91 citations2016: 80 citations2017: 93 citations2018: 65 citations2019: 236 citations2020: 290 citations2021: 264 citations2022: 180 citations2023: 118 citations2024: 177 citations2025: 64 citations1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 504 citing papers, 17.3% of this breakdownUnited Kingdom: 380 citing papers, 13.1% of this breakdownFrance: 201 citing papers, 6.9% of this breakdownGermany: 197 citing papers, 6.8% of this breakdownNetherlands: 172 citing papers, 5.9% of this breakdownItaly: 153 citing papers, 5.3% of this breakdownCanada: 109 citing papers, 3.7% of this breakdownChina: 107 citing papers, 3.7% of this breakdownJapan: 103 citing papers, 3.5% of this breakdownSweden: 99 citing papers, 3.4% of this breakdownAustralia: 85 citing papers, 2.9% of this breakdownSpain: 71 citing papers, 2.4% of this breakdown
0%17.3%Other 25.1%

Fields

  • Medicine90.7%
  • Immunology and Microbiology5.4%
  • Biochemistry, Genetics and Molecular Biology2.9%
  • Neuroscience0.3%
  • Materials Science0.2%
  • Other0.5%

Topics

  • Vasculitis and related conditions24.3%
  • Otitis Media and Relapsing Polychondritis6.2%
  • Systemic Sclerosis and Related Diseases5.2%
  • Sarcoidosis and Beryllium Toxicity Research4.3%
  • Renal Diseases and Glomerulopathies4%
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema3.8%
  • Other52.2%

Coauthors

All papers

Open in search
  1. Long-term patient survival in ANCA-associated vasculitis

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 930

  2. Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 1,116

  3. Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

    Authors: , , , , , , , , , , , , , , - Annals of Internal Medicine 2009 cited by 948

  4. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2017 cited by 451

  5. Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement

    Authors: , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 292

  6. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2012 cited by 6,579

  7. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

    Authors: , , , , , , , , - Arthritis & Rheumatism 2005 cited by 796

  8. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 cited by 227

  9. Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , - Journal of the American Society of Nephrology 2006 cited by 259

  10. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 194

  11. A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 1,361

  12. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

    Authors: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2011 cited by 429

  13. Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups

    Authors: , , , , , , , , , - Kidney International 2002 cited by 320

  14. Development of comprehensive disease assessment in systemic vasculitis

    Authors: , , , , , , , - Postgraduate Medical Journal 2006 cited by 177

  15. Exercise-induced laryngeal obstructions: prevalence and symptoms in the general public

    Authors: , , , - European Archives of Oto-Rhino-Laryngology 2011 cited by 168

  16. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis

    Authors: , , , , , , , , , , - Kidney International 2013 cited by 105

  17. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis

    Authors: , , , , , , , , , , , , - Kidney International 1998 cited by 745

  18. ERS/ELS/ACCP 2013 international consensus conference nomenclature on inducible laryngeal obstructions

    Authors: , , , , , , , , , , , , - European Respiratory Review 2015 cited by 175

  19. Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Chemistry and Laboratory Medicine (CCLM) 2020 cited by 26

  20. AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS

    Authors: , , , , , , , , - The Lancet 1985 cited by 1,902

  21. Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients

    Authors: , , , , , , , , , - Kidney International 2002 cited by 221

  22. Brief Report: Long‐term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

    Authors: , , , , , , , - Arthritis & Rheumatism 2012 cited by 152

  23. Chances of Renal Recovery for Dialysis-Dependent ANCA-Associated Glomerulonephritis

    Authors: , , , , , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 126

  24. 875 Cases of bacterial meningitis: Diagnostic procedures and the impact of preadmission antibiotic therapy Part III of a three-part series

    Authors: , , , , , , - Journal of Infection 1983 cited by 112